Last 27 quarters of trend data · Healthcare · Medical - Diagnostics & Research
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Sotera Health Company's quarterly P/E stands at 39.8x. EV/EBITDA has expanded 41.0% YoY to 19.3x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 58.59 | 39.83 | 36.75 | 23.13 | 99.64 | — | 78.62 | 70.17 | 96.66 | 135.25 | 30.09 | — | 57.02 |
| — | — | -53.3% | -67.0% | +3.1% | — | +161.3% | — | +69.5% | -69.8% | — | — | +28.1% | |
| P/S Ratio | 3.88 | 3.68 | 4.16 | 3.62 | 2.70 | 3.25 | 3.36 | 4.18 | 3.05 | 3.44 | 3.85 | 4.00 | 5.22 |
| — | +13.4% | +24.0% | -13.3% | -11.6% | -5.5% | -12.7% | +4.4% | -41.6% | -40.2% | +65.8% | +108.3% | +1.5% | |
| P/B Ratio | 7.48 | 6.63 | 8.34 | 8.19 | 6.21 | 7.98 | 9.63 | 10.14 | 7.99 | 7.95 | 10.76 | 11.16 | 12.75 |
| — | -17.0% | -13.4% | -19.2% | -22.2% | +0.5% | -10.5% | -9.1% | -37.3% | -43.4% | +61.3% | +254.2% | +47.8% | |
| P/FCF | 30.24 | — | 24.31 | 33.77 | 30.34 | 23.22 | — | 20.13 | 43.58 | — | 24.71 | — | — |
| — | — | — | +67.7% | -30.4% | — | — | — | — | — | +27.8% | — | — | |
| EV / EBITDA | 21.23 | 19.27 | 9.86 | 11.79 | 10.47 | 13.67 | 11.71 | 13.80 | 11.74 | 14.68 | 11.75 | 13.77 | 18.01 |
| — | +41.0% | -15.8% | -14.5% | -10.8% | -6.9% | -0.4% | +0.2% | -34.8% | -36.5% | +14.4% | +52.7% | +8.7% | |
| EV / EBIT | 16.39 | 19.27 | 16.53 | 14.47 | 21.81 | 51.32 | 17.37 | 20.22 | 24.66 | 26.03 | 15.71 | 38.28 | 28.36 |
| — | -62.5% | -4.8% | -28.4% | -11.6% | +97.1% | +10.6% | -47.2% | -13.0% | -47.1% | — | +179.9% | -1.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Sotera Health Company's operating margin was 28.2% in Q1 2026, down 16.7 pp QoQ and up 5.7 pp YoY. The trailing four-quarter average of 34.7% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.5% | 52.5% | 54.7% | 57.0% | 56.6% | 53.2% | 56.6% | 55.4% | 55.2% | 51.2% | 58.0% | 55.5% | 54.7% |
| — | -1.3% | -3.5% | +3.0% | +2.5% | +3.9% | -2.4% | -0.2% | +1.0% | +1.3% | +3.0% | +1.4% | -3.1% | |
| Operating Margin | 33.8% | 28.2% | 44.9% | 35.7% | 30.0% | 22.4% | 30.0% | 28.2% | 27.8% | 21.4% | 33.5% | 28.9% | 24.8% |
| — | +25.6% | +49.4% | +26.6% | +8.2% | +4.6% | -10.4% | -2.5% | +12.1% | +41.7% | +40.2% | +13.8% | -7.7% | |
| Net Margin | 6.7% | 9.5% | 11.5% | 15.5% | 2.7% | -5.2% | 4.2% | 6.0% | 3.2% | 2.5% | 12.5% | -5.2% | 9.2% |
| — | +282.2% | +170.4% | +161.1% | -14.5% | -304.5% | -65.9% | +214.7% | -65.6% | +97.7% | +109.8% | -151.4% | -19.3% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.4% | 4.3% | 6.0% | 9.1% | 1.7% | -3.2% | 2.8% | 3.8% | 2.1% | 1.4% | 9.4% | -3.4% | 6.0% |
| — | +233.7% | +114.0% | +139.5% | -16.2% | -323.6% | -70.1% | +210.9% | -65.9% | +81.3% | +114.1% | -185.0% | +26.7% | |
| ROA | 2.5% | 0.8% | 1.1% | 1.5% | 0.3% | -0.4% | 0.4% | 0.5% | 0.3% | 0.2% | 1.3% | -0.4% | 0.7% |
| — | +290.3% | +172.7% | +176.0% | -11.9% | -310.4% | -68.4% | +222.5% | -60.5% | +134.8% | +111.6% | -150.3% | -32.4% | |
| ROIC | 11.8% | 2.3% | 4.0% | 3.3% | 2.7% | 1.7% | 2.6% | 2.4% | 2.3% | 1.6% | 3.2% | 2.3% | 2.1% |
| — | +33.5% | +54.3% | +37.8% | +16.4% | +8.5% | -17.3% | +3.6% | +9.0% | +28.6% | +49.4% | +12.4% | -8.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Sotera Health Company's Debt/EBITDA ratio is 28.8x, up from 12.9x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 14.8% YoY to 2.82x, strengthening the short-term liquidity position. Debt/Equity has declined for 6 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 3.75 | 3.65 | 3.75 | 4.14 | 4.60 | 5.67 | 5.81 | 5.01 | 5.55 | 5.46 | 5.24 | 6.16 | 5.56 |
| — | -35.6% | -35.4% | -17.5% | -17.2% | +3.7% | +10.7% | -18.6% | -0.1% | -15.1% | -9.6% | +104.0% | +92.4% | |
| Debt / EBITDA | 7.50 | 28.79 | 12.85 | 16.56 | 18.95 | 23.98 | 18.44 | 19.08 | 20.12 | 25.07 | 16.08 | 20.36 | 22.64 |
| — | +20.1% | -30.3% | -13.2% | -5.8% | -4.3% | +14.7% | -6.3% | -11.1% | -21.4% | -23.5% | +10.3% | +33.6% | |
| Current Ratio | 2.46 | 2.82 | 2.46 | 2.38 | 2.47 | 2.46 | 2.75 | 2.88 | 2.93 | 3.20 | 2.42 | 2.59 | 2.73 |
| — | +14.8% | -10.8% | -17.3% | -15.8% | -23.2% | +14.0% | +11.3% | +7.5% | +107.8% | +196.5% | -13.8% | -2.8% | |
| Quick Ratio | 2.24 | 2.52 | 2.24 | 2.16 | 2.23 | 2.19 | 2.50 | 2.61 | 2.59 | 2.86 | 2.21 | 2.40 | 2.52 |
| — | +15.2% | -10.3% | -17.3% | -14.2% | -23.6% | +13.2% | +8.6% | +2.9% | +95.8% | +187.3% | -12.3% | -0.4% | |
| Interest Coverage | 1.95 | 2.27 | 3.01 | 2.86 | 1.46 | 0.64 | 2.10 | 2.03 | 1.37 | 1.26 | 2.54 | 1.01 | 2.12 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 27 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SHC stock.
Sotera Health Company's current P/E is 58.6x. The average P/E over the last 4 quarters is 49.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Sotera Health Company's current operating margin is 33.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Sotera Health Company's business trajectory between earnings reports.